273 related articles for article (PubMed ID: 23590927)
1. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
[TBL] [Abstract][Full Text] [Related]
2. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
van der Meer FJ; Velthorst E;
Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.
Pelayo-Terán JM; Diaz FJ; Pérez-Iglesias R; Suárez-Pinilla P; Tabarés-Seisdedos R; de León J; Crespo-Facorro B
Psychol Med; 2014 Jan; 44(1):37-50. PubMed ID: 23461899
[TBL] [Abstract][Full Text] [Related]
4. Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial.
Faber G; Smid HG; Van Gool AR; Wunderink L; van den Bosch RJ; Wiersma D
J Clin Psychiatry; 2012 May; 73(5):632-8. PubMed ID: 22394457
[TBL] [Abstract][Full Text] [Related]
5. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
6. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
Toftdahl NG; Nordentoft M; Hjorthøj C
J Dual Diagn; 2016; 12(2):129-36. PubMed ID: 27070732
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use at a young age is associated with psychotic experiences.
Schubart CD; van Gastel WA; Breetvelt EJ; Beetz SL; Ophoff RA; Sommer IE; Kahn RS; Boks MP
Psychol Med; 2011 Jun; 41(6):1301-10. PubMed ID: 20925969
[TBL] [Abstract][Full Text] [Related]
9. Reasons for cannabis use in men with and without psychosis.
Green B; Kavanagh DJ; Young RM
Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use and expression of mania in the general population.
Henquet C; Krabbendam L; de Graaf R; ten Have M; van Os J
J Affect Disord; 2006 Oct; 95(1-3):103-10. PubMed ID: 16793142
[TBL] [Abstract][Full Text] [Related]
11. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
Thornton LK; Baker AL; Johnson MP; Lewin T
Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
[TBL] [Abstract][Full Text] [Related]
12. Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study.
Kuepper R; van Os J; Lieb R; Wittchen HU; Henquet C
Psychol Med; 2011 Oct; 41(10):2121-9. PubMed ID: 21466750
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study.
Bergé D; Mané A; Salgado P; Cortizo R; Garnier C; Gomez L; Diez-Aja C; Bulbena A; Pérez V
Psychiatr Serv; 2016 Feb; 67(2):227-33. PubMed ID: 26467909
[TBL] [Abstract][Full Text] [Related]
14. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.
van Gastel WA; Vreeker A; Schubart CD; MacCabe JH; Kahn RS; Boks MP
Schizophr Res; 2014 Aug; 157(1-3):266-70. PubMed ID: 24930951
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in people with a psychotic illness: is cannabis protective?
Waterreus A; Di Prinzio P; Watts GF; Castle D; Galletly C; Morgan VA
Psychol Med; 2016 Jun; 46(8):1651-62. PubMed ID: 26965714
[TBL] [Abstract][Full Text] [Related]
16. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
17. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
Wong MM; Chen EY; Lui SS; Tso S
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
[TBL] [Abstract][Full Text] [Related]
18. Subjective effects of cannabis before the first psychotic episode.
Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
[TBL] [Abstract][Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study.
Barbeito S; Vega P; Ruiz de Azúa S; Saenz M; Martinez-Cengotitabengoa M; González-Ortega I; Bermudez C; Hernanz M; Corres BF; González-Pinto A
BMC Psychiatry; 2013 Dec; 13():326. PubMed ID: 24289797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
